Evidence map›Paper›PMID 38952058›Full record

ArticleDrug delivery2024

Genistein transfersome-embedded topical delivery system for skin melanoma treatment:

Amira Motawea, Sara N Maria, Doaa N Maria, Monica M Jablonski, Mohamed Moustafa Ibrahim

Abstract read
In one paragraph

Article in Drug delivery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amira MotaweaDepartment of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Sara N MariaDepartment of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Doaa N MariaDepartment of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Monica M JablonskiDepartment of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN, USA.
Mohamed Moustafa IbrahimDepartment of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

Funding

Novel Extended Release Glaucoma Therapy for Once Daily DosingR24EY029950 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI JABLONSKI, MONICA M · 2020 to 2024
$5.3M
NEI NIH HHS R24 EY029950
6 · The paper itself

Abstract

Skin melanoma is considered the most dangerous form of skin cancer due to its association with high risk of metastasis, high mortality rate and high resistance to different treatment options. Genistein is a natural isoflavonoid with known chemotherapeutic activity. Unfortunately, it has low bioavailability due to its poor aqueous solubility and excessive metabolism. In the current study, genistein was incorporated into transferosomal hydrogel to improve its bioavailability. The prepared transferosomal formulations were characterized regarding: particle size; polydispersity index; zeta potential; encapsulation efficiency; TEM; FTIR; DSC; XRD;

Indexed as

Drug LiberationGenisteinHydrogelsMelanomaParticle SizeSkin NeoplasmsAdministration, CutaneousAntineoplastic AgentsBiological AvailabilityCell Line, TumorChemistry, PharmaceuticalDrug CarriersDrug Delivery SystemsDrug StabilityHumansSolubilityAntineoplastic AgentsDrug CarriersGenisteinHydrogelscol T-gelGenisteinlive/dead assaymelanoma spheroidsstabilitytransfersomes

Identifiers

PMID38952058
PMCPMC11221477

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.